Emyria Aktie

Emyria will launch its first New South Wales clinic in Sydney in September 2026, expanding its national footprint across QLD, VIC and WA. The site is fitted with four treatment rooms and has secured pharmacy arrangements and an agreement with Matilda Nepean Private Hospital. About 20 therapists and four psychiatrists (two authorised prescribers) are in place, and the first patients approved via workers compensation are set to begin treatment after opening. The move supports Emyria’s strategy to scale a national clinical network for intensive and emerging mental health therapies. » Więcej na smallcaps.com.au

Emyria reported revenue of just over AUD 4 million for fiscal year 2026, an increase of 207.7% year‑on‑year, and reports total cash of around AUD 4.3 million. The clinic network was expanded from one to five operational sites, the Perth clinic has reached breakeven, and the number of patients treated rose to 138 from 24 in the prior year. Management plans further capacity increases, hospital partnerships and a Sydney opening in early 2027, but still anticipates needing capital during the expansion. The stock reacted muted and fell in after‑hours trading as investors wait for further evidence of sustainable group earnings. » Więcej na de.investing.com